Mankind Pharma Ltd is a 34-year-old pharma company led by Mr Ramesh Juneja (Chairman & Whole-Time Director), Mr Rajeev Juneja (Vice Chairman & MD), and Mr Sheetal Arora (CEO & Whole-Time Director), and they have a more than 21,000-strong workforce. They are present in 25 countries. Their products are Pharmaceuticals, Generic drugs, OTC, FMCG, Diagnostics, etc. Mankind has shown nearly 100% growth in its share price in the last 5 years. However, their revenue is 12,207 crore and their net profit is 2,007 crore for FY 2024-25.

Establishment:

New Delhi in 1991 by Mr. Ramesh C. Juneja and Rajeev Juneja

Company Listed On:

National Stock Exchange (NSE) and Bombay Stock Exchange (BSE)

Core Business:

Pharmaceuticals, Generic Drugs, OTC Products, FMCG, Diagnostics

Financial Performance:

Revenue of ₹12,207 crore and net profit of ₹2,007 crore for FY 2024–25
Strong share price growth of nearly 100% over the last 5 years

Future Outlook:

• Global Expansion
• Involvements into FMCG and diagnostics segments
• Involvements into affordable healthcare and generic medicines
• Focused on innovation and brand building

Disclaimer:

Unsold 70 publishes research-based articles, blogs, news, and company profiles to help readers understand businesses along with their future prospects. It will help you learn about the stock market and mutual funds. We research the companies as per our algorithm and find companies that need further research. However, the Mankind Pharma Ltd company profile is not an investment recommendation, as past performance does not guarantee future results. You should perform your own research and seek advice from a SEBI-registered financial advisor before making investment decisions. Visit our weekly research page to know about the research work done by our research team. It will help you to take up the companies for further research.